Guiyu Zhang

1.6k citations
45 papers · 1.2k indexed · 1 hit paper · h-index 18

Guiyu Zhang

41 papers receiving 1.2k citations

Hit Papers

FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6...3042020202620222024100200300

Peers

Guiyu Zhang
Comparison fields: 5 of 115
  • Cancer Research 285
  • Pharmacology 134
  • Pulmonary and Respiratory Medicine 314
  • Molecular Biology 609
  • Complementary and alternative medicine 70
Replace Dae‐Woon Eom with:
Dae‐Woon Eom South Korea
Aya Naiki‐Ito Japan
Jian Liang China
Yongheng Bai China
Junhua Zheng China
Huayao Li China
Wanyin Wu China
Desong Kong China
Hongfei Wu China
Guiyu Zhang relative to Dae‐Woon Eom South Korea Dae‐Woon Eom's profile →
Citations per field
00.5×3.6×
Dae‐Woon Eom · 1×
Citations per year

Countries citing papers authored by Guiyu Zhang

Since Specialization
Citations

This map shows the geographic impact of Guiyu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiyu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiyu Zhang more than expected).

Fields of papers citing papers by Guiyu Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiyu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiyu Zhang. The network helps show where Guiyu Zhang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Guiyu Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guiyu Zhang Line = papers co-authored together Guiyu Zhang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20258
3 20250
4 20256
5 20240
6 20247
7 20249
8 202336
9 20231
10 202338
11 202112
12 20216
13
FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Diseasebreakdown →
2020304
14 202061
15 201927
16 201630
17 20157
18 20141
19 201453
20 201111

About Guiyu Zhang

Guiyu Zhang is a scholar working on Pharmacology, Reproductive Medicine and Cancer Research, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Plant-based Medicinal Research (6 papers), Circular RNAs in diseases (6 papers), Genomics and Phylogenetic Studies (4 papers), Berberine and alkaloids research (4 papers), Traditional Chinese Medicine Analysis (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (285 citations), Pharmacology (134 citations) and Pulmonary and Respiratory Medicine (314 citations). Guiyu Zhang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Linlin Lu, Jinjun Wu, Caiping Zhao, Hang Li, Dongfeng Chen, Meiling Zhu, Juan Lü, Xuelei Liu, Weihong Kuang and Ye Tian. Their work appears in journals such as Journal of Cleaner Production, Scientific Reports and Free Radical Biology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026